Top Story

Xiidra first FDA-approved drug for signs and symptoms of dry eye disease

July 28, 2016

The FDA approved Xiidra for the treatment of signs and symptoms of dry eye disease in adult patients on July 11.

Manufactured by Shire, Xiidra (lifitegrast ophthalmic solution 5%) is the first prescription eye drop medication in a new class of drugs, a lymphocyte function-associated antigen 1 antagonist, to be approved by the FDA for dry eye disease, according to an FDA press release. The drug’s safety and efficacy were assessed in more than 2,500 patients in four separate, randomized controlled studies. The results of the studies found that patients treated with Xiidra demonstrated improvement in their signs and symptoms of dry eye compared with patients treated with placebo.

FDA News

CenterVue launches training module to aid low vision patients

July 28, 2016
CenterVue announced 510(k) clearance for its fixation training for the MAIA platform, a technology designed to help patients rehabilitate from vision loss using audio…

pSivida’s Medidur maintains primary endpoint results at 12 months

July 28, 2016
Medidur statistically significantly prevented recurrence of posterior uveitis through 12 months, pSivida announced in a press release. Prevention of recurrence of…
Meeting News Coverage

Researchers find association between retinal nerve fiber layer thinning, poor cognition

July 28, 2016
Patients who scored abnormally on any one cognition test had a thinner retinal nerve fiber layer thickness compared with patients who did not score abnormally, according…
Meeting News CoverageVideo

VIDEO: Speaker talks about persistent iritis after cataract surgery

July 28, 2016
At Kiawah Eye, Kristin Neatrour, MD, presents results of a study evaluating patients with postoperative iritis after cataract surgery to determine the prevalence and…
More News Headlines »
Original Article

Clinical Outcomes of Frontalis Sling Using Silicone Rod With Two-point Brow Incisions in Blepharoptosis

Journal of Pediatric Ophthalmology and Strabismus, July/August 2016, Volume 53 Issue 4
To investigate the functional and cosmetic outcomes of the modified frontalis sling operation using silicone rod with…
More »

Clinical Trials in Diabetic Retinopathy

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Highlights from ASCRS

Highlights from ASCRS

Meeting News Coverage

VIDEO: OCT screening before cataract surgery eliminates postoperative visual surprises

July 20, 2016
More »